JPY 227.0
(-0.44%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 6.39 Billion JPY | -34.47% |
2022 | 9.76 Billion JPY | -14.45% |
2021 | 11.41 Billion JPY | -1.37% |
2020 | 11.56 Billion JPY | 79.73% |
2019 | 6.43 Billion JPY | 16.94% |
2018 | 5.5 Billion JPY | 7.32% |
2017 | 5.12 Billion JPY | -11.64% |
2016 | 5.8 Billion JPY | -0.27% |
2015 | 5.82 Billion JPY | -9.82% |
2014 | 6.45 Billion JPY | -11.57% |
2013 | 7.29 Billion JPY | -36.47% |
2012 | 11.48 Billion JPY | 150.62% |
2011 | 4.58 Billion JPY | -0.4% |
2010 | 4.6 Billion JPY | -12.14% |
2009 | 5.23 Billion JPY | 27.05% |
2008 | 4.12 Billion JPY | -2.4% |
2007 | 4.22 Billion JPY | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 FY | 6.39 Billion JPY | -34.47% |
2023 Q4 | 6.39 Billion JPY | -5.36% |
2023 Q3 | 6.75 Billion JPY | -21.97% |
2023 Q2 | 8.66 Billion JPY | -6.01% |
2023 Q1 | 9.21 Billion JPY | -5.59% |
2022 Q1 | 11.15 Billion JPY | -2.27% |
2022 FY | 9.76 Billion JPY | -14.45% |
2022 Q4 | 9.76 Billion JPY | -8.46% |
2022 Q3 | 10.66 Billion JPY | -2.94% |
2022 Q2 | 10.98 Billion JPY | -1.48% |
2021 FY | 11.41 Billion JPY | -1.37% |
2021 Q1 | 11.37 Billion JPY | -1.69% |
2021 Q4 | 11.41 Billion JPY | 3.66% |
2021 Q3 | 11 Billion JPY | 7.5% |
2021 Q2 | 10.23 Billion JPY | -9.97% |
2020 Q1 | 6.9 Billion JPY | 7.25% |
2020 Q2 | 8.98 Billion JPY | 30.22% |
2020 Q4 | 11.56 Billion JPY | 16.9% |
2020 FY | 11.56 Billion JPY | 79.73% |
2020 Q3 | 9.89 Billion JPY | 10.08% |
2019 FY | 6.43 Billion JPY | 16.94% |
2019 Q1 | 5.27 Billion JPY | -4.23% |
2019 Q2 | 5.74 Billion JPY | 9.02% |
2019 Q3 | 5.78 Billion JPY | 0.74% |
2019 Q4 | 6.43 Billion JPY | 11.18% |
2018 Q2 | 5.51 Billion JPY | 8.37% |
2018 Q4 | 5.5 Billion JPY | -3.51% |
2018 FY | 5.5 Billion JPY | 7.32% |
2018 Q1 | 5.08 Billion JPY | -0.83% |
2018 Q3 | 5.7 Billion JPY | 3.5% |
2017 Q4 | 5.12 Billion JPY | -3.44% |
2017 FY | 5.12 Billion JPY | -11.64% |
2017 Q3 | 5.31 Billion JPY | -2.62% |
2017 Q2 | 5.45 Billion JPY | -2.77% |
2017 Q1 | 5.6 Billion JPY | -3.36% |
2016 Q4 | 5.8 Billion JPY | 6.94% |
2016 Q3 | 5.42 Billion JPY | -2.73% |
2016 Q1 | 5.35 Billion JPY | -7.91% |
2016 Q2 | 5.58 Billion JPY | 4.12% |
2016 FY | 5.8 Billion JPY | -0.27% |
2015 Q2 | 7.55 Billion JPY | 2.08% |
2015 Q1 | 7.39 Billion JPY | 14.61% |
2015 Q4 | 5.82 Billion JPY | -18.3% |
2015 Q3 | 7.12 Billion JPY | -5.65% |
2015 FY | 5.82 Billion JPY | -9.82% |
2014 Q2 | 6.53 Billion JPY | 3.06% |
2014 FY | 6.45 Billion JPY | -11.57% |
2014 Q4 | 6.45 Billion JPY | -3.99% |
2014 Q3 | 6.72 Billion JPY | 2.86% |
2014 Q1 | 6.34 Billion JPY | -13.11% |
2013 Q2 | 8.03 Billion JPY | -1.84% |
2013 Q3 | 7.87 Billion JPY | -2.02% |
2013 Q4 | 7.29 Billion JPY | -7.32% |
2013 Q1 | 8.18 Billion JPY | -28.73% |
2013 FY | 7.29 Billion JPY | -36.47% |
2012 Q1 | 5.18 Billion JPY | 13.12% |
2012 Q3 | 5.13 Billion JPY | -4.72% |
2012 Q4 | 11.48 Billion JPY | 123.95% |
2012 FY | 11.48 Billion JPY | 150.62% |
2012 Q2 | 5.38 Billion JPY | 3.83% |
2011 Q4 | 4.58 Billion JPY | 1.56% |
2011 FY | 4.58 Billion JPY | -0.4% |
2011 Q3 | 4.51 Billion JPY | -0.69% |
2011 Q2 | 4.54 Billion JPY | -5.23% |
2011 Q1 | 4.79 Billion JPY | 4.19% |
2010 Q1 | 5.29 Billion JPY | 1.1% |
2010 FY | 4.6 Billion JPY | -12.14% |
2010 Q3 | 5.04 Billion JPY | 7.71% |
2010 Q4 | 4.6 Billion JPY | -8.72% |
2010 Q2 | 4.68 Billion JPY | -11.61% |
2009 Q4 | 5.23 Billion JPY | -11.1% |
2009 Q3 | 5.89 Billion JPY | 20.32% |
2009 Q2 | 4.89 Billion JPY | 13.33% |
2009 Q1 | 4.32 Billion JPY | 4.8% |
2009 FY | 5.23 Billion JPY | 27.05% |
2008 Q4 | 4.12 Billion JPY | 0.38% |
2008 Q3 | 4.1 Billion JPY | 2.5% |
2008 Q2 | 4 Billion JPY | 0.0% |
2008 FY | 4.12 Billion JPY | -2.4% |
2007 FY | 4.22 Billion JPY | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Shin Nippon Biomedical Laboratories, Ltd. | 76.3 Billion JPY | 91.617% |
DNA Chip Research Inc. | 982.47 Million JPY | -551.061% |
Cosmo Bio Company,Limited | 10.87 Billion JPY | 41.165% |
H.U. Group Holdings, Inc. | 295.35 Billion JPY | 97.834% |
FALCO HOLDINGS Co., Ltd. | 36.42 Billion JPY | 82.439% |
BML, Inc. | 170.99 Billion JPY | 96.259% |
Human Metabolome Technologies, Inc. | 2.6 Billion JPY | -145.699% |